Trupanion (NASDAQ:TRUP – Get Free Report) and Aflac (NYSE:AFL – Get Free Report) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, institutional ownership, risk, dividends and earnings.
Volatility & Risk
Trupanion has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500. Comparatively, Aflac has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500.
Institutional and Insider Ownership
67.4% of Aflac shares are held by institutional investors. 5.6% of Trupanion shares are held by company insiders. Comparatively, 0.8% of Aflac shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Trupanion | 1.71% | 6.71% | 2.89% |
| Aflac | 21.24% | 12.82% | 3.30% |
Analyst Ratings
This is a summary of current recommendations for Trupanion and Aflac, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Trupanion | 0 | 5 | 1 | 0 | 2.17 |
| Aflac | 4 | 8 | 3 | 1 | 2.06 |
Trupanion currently has a consensus target price of $40.00, suggesting a potential upside of 9.05%. Aflac has a consensus target price of $118.73, suggesting a potential downside of 5.20%. Given Trupanion’s stronger consensus rating and higher probable upside, analysts clearly believe Trupanion is more favorable than Aflac.
Valuation & Earnings
This table compares Trupanion and Aflac”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Trupanion | $1.44 billion | 1.10 | $19.43 million | $0.61 | 60.13 |
| Aflac | $17.16 billion | 3.61 | $3.65 billion | $6.86 | 18.26 |
Aflac has higher revenue and earnings than Trupanion. Aflac is trading at a lower price-to-earnings ratio than Trupanion, indicating that it is currently the more affordable of the two stocks.
Summary
Aflac beats Trupanion on 10 of the 15 factors compared between the two stocks.
About Trupanion
Trupanion provides medical insurance for cats and dogs, offering coverage for eligible veterinary care. Its products are designed to help pet owners manage unexpected costs from illnesses and injuries, subject to policy terms and exclusions. The company also provides software and payment services that enable participating veterinary practices to submit claims and receive payments directly, reducing the need for customers to pay covered costs upfront and seek reimbursement. Founded in 2000 and headquartered in Seattle, Trupanion serves customers in the United States and Canada.
About Aflac
Aflac Incorporated is an insurance company that provides supplemental health and life insurance to individuals and businesses. Its products are designed to help customers manage expenses that may not be covered by major medical insurance, including costs associated with accidents, cancer, critical illness and hospital stays. The company operates primarily in the United States and Japan. In the U.S., Aflac offers workplace benefits such as accident, disability, dental, vision and life insurance. In Japan, it provides products including cancer, medical and life insurance.
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
